Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization.

@article{Azoulay2000ResectionON,
  title={Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization.},
  author={D. Azoulay and D. Castaing and A. Smail and R. Adam and V. Cailliez and A. Laurent and A. Lemoine and H. Bismuth},
  journal={Annals of surgery},
  year={2000},
  volume={231 4},
  pages={
          480-6
        }
}
OBJECTIVE To assess the influence of preoperative portal vein embolization (PVE) on the long-term outcome of liver resection for colorectal metastases. SUMMARY BACKGROUND DATA Preoperative PVE of the liver induces hypertrophy of the remnant liver and increases the safety of hepatectomy. METHODS Thirty patients underwent preoperative PVE and 88 patients did not before resection of four or more liver segments. PVE was performed when the estimated rate of remnant functional liver parenchyma… Expand
Percutaneous Portal Vein Embolization Increases the Feasibility and Safety of Major Liver Resection for Hepatocellular Carcinoma in Injured Liver
TLDR
With the use of PVE, more patients with previously unresectable HCC in injured liver can benefit from resection, and long-term survival rates are comparable to those after resection without PVE. Expand
Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival.
TLDR
The long-term survival rate after PVE followed by resection is comparable with the survival rate obtained after resection without preoperative PVE, and this technique increases the suitability of resection as a treatment choice for patients with liver metastases. Expand
Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial
TLDR
Before elective right hepatectomy, the hypertrophy of FLR induced by PVE had no beneficial effect on the postoperative course in patients with normal liver, and before chronic liver disease, PVE significantly decreased the incidence of postoperative complications as well as the intensive care unit stay and total hospital stay. Expand
Oncological Outcomes of Major Liver Resection Following Portal Vein Embolization: A Systematic Review and Meta-analysis
TLDR
PVE does not have any adverse effect on PHR or OS in patients undergoing major liver resection for CRLM in patients with colorectal liver metastases (CRLM), and further studies are needed to provide definitive answers. Expand
Does portal vein embolization prior to liver resection influence the oncological outcomes - A propensity score matched comparison.
  • J. Huiskens, P. Olthof, +11 authors T. V. van Gulik
  • Medicine
  • European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2018
TLDR
This retrospective, matched analysis does not suggest a negative impact of PVE on long-term outcomes after liver resection in patients with CRLM. Expand
Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization.
TLDR
Portal vein embolization enables safe and potentially curative extended hepatectomy in a subset of patients who would otherwise be marginal candidates for resection based on a small liver remnant size. Expand
One-Stage Hepatectomy Following Portal Vein Embolization for Colorectal Liver Metastasis
TLDR
The authors' one-stage hepatectomy policy of using PVE provides acceptable morbidity and favorable long-term outcomes and the variable performance/nonperformance of PVE was not detected as an independent predictor of poor survival. Expand
Long-Term Survival and Disease Recurrence Following Portal Vein Embolisation Prior to Major Hepatectomy for Colorectal Metastases
TLDR
It is concluded that PVE significantly increases the future liver remnant and only two-thirds of patients proceed to resection because of disease progression, and long-term survival is less than in patients who do not require PVE. Expand
Preoperative Portal Vein Embolization for Extended Hepatectomy
TLDR
Preoperative PVE is a safe and effective method of increasing the remnant liver volume in patients with estimated postresection volumes of less than 25% appears to reduce postoperative liver dysfunction. Expand
Tumor Progression After Preoperative Portal Vein Embolization
TLDR
Portal vein embolization is associated with increased TGR and new tumor in the FRL and recurrent tumor after resection and short intervals and interval chemotherapy between PVE and resection are advised. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 43 REFERENCES
Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery.
TLDR
The authors conclude that PVE is safe and well tolerated and induces marked hypertrophy of the unembolized parenchyma in noncirrhotic patients and allows hepatectomy to be performed under safe conditions when the FRL volume is initially insufficient. Expand
Resection for multiple metastatic liver tumors after portal embolization.
TLDR
The presence of bilateral multiple metastatic liver lesions from colorectal cancer is not considered a contraindication for hepatic resection if thorough examination of the liver is performed with intraoperative ultrasonography and the surgical risk is minimal. Expand
New possibilities for major liver surgery in patients with Klatskin tumors or primary hepatocellular carcinoma--an old problem revisited.
TLDR
The present results support the policy of selective portal embolization in patients with impaired liver function in whom extensive liver resection is necessary and suggest Embolization is a promising ancillary preoperative alternative. Expand
Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy.
TLDR
Liver resection may be achieved in some previously unresectable patients with the help of an effective chemotherapy, and the benefit in survival seems comparable to that obtained with primary liver resection. Expand
Preoperative portal vein embolization for extension of hepatectomy indications
TLDR
Although exclusively applicable in a limited subset of patients, POPE widens the possibilities of curative hepatectomies, because it induces sound hypertrophy of unembolized liver segments, and Cyanoacrylate seems to ensure better and fasterhypertrophy. Expand
Preoperative portal vein embolization: An audit of 84 patients
TLDR
PVE by gelatin sponge powder is a safe and effective preoperative maneuver that induces hypertrophy of the section of the liver that will remain after partial hepatectomy, and is a great advantage that gelatin sponge causes minimal damage. Expand
Radical operation after portal embolization for tumor of hilar bile duct.
The clinical outcomes of patients with carcinoma of the proximal bile duct who underwent portal embolization of the right lobe followed by right extended lobectomy with (n = 3) and without (n = 9)Expand
Preoperative selective portal vein embolizations are an effective means of extending the indications of major hepatectomy in the normal and injured liver.
TLDR
With this technique, liver tumors considered to be unresectable, due to life-threatening volumetric insufficiency, may be considered resectable lesions, and there is an increase in the safety of some extended hepatectomies. Expand
Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure.
TLDR
Alkaline phosphatase is a good indicator of hepatic regeneration in the absence of jaundice in patients after hepatectomy, and more discriminant tests are recommended than conventional hepatic function tests in patients with large tumors associated with high alkalineosphatase levels. Expand
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report.
TLDR
A portal venous branch was embolized before surgery to induce atrophy of the lobe to be resected and hypertrophy ofThe contralateral lobe in 14 patients with hilar bile duct carcinoma with jaundice to minimize postoperative liver dysfunction. Expand
...
1
2
3
4
5
...